Application 211624
- Type
- ANDA
- Sponsor
- SUNGEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | POWDER;INTRAVENOUS | EQ 150MG BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70625-300 | Fosaprepitant | Fosaprepitant Dimeglumine | SunGen Pharma, LLC | ANDA | Current |
| 70625-300 | Fosaprepitant | Fosaprepitant Dimeglumine | SunGen Pharma, LLC | ANDA | Current |
| 70860-780 | Fosaprepitant | fosaprepitant dimeglumine | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 70860-780 | Fosaprepitant | fosaprepitant dimeglumine | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 72606-569 | Fosaprepitant | Fosaprepitant Dimeglumine | CELLTRION USA, INC. | ANDA | Current |